Markets/FDA approves Sanofi's Dupixent?

FDA approves Sanofi's Dupixent?

Market Price

80%YES

20%NO

Vol 24h$3K

Liquidity$3K

Bid / Ask74% / 83%

Spread9.00pp

ClosesApr 27, 2026

✦ Deep AI Analysis🔒 PRO

The market's precipitous 15pp decline over seven trading sessions reflects mounting uncertainty around the diplomatic timeline. Cross-venue signals show institutional venues pricing 6pp below Polymarket.

The FM model flags a structural overpricing: with less than 10 days to expiry and no confirmed diplomatic channel active, the Bayesian update pushes the model estimate well below current market price. Three correlated outcome markets collectively imply only a 23% chance any deadline resolves YES.

Watch for: official bilateral statements, foreign ministry press briefings, and whether the longer-dated outcome markets begin to converge as a leading indicator of changed expectations.

Synthesizes price, cross-venue gaps, Bayesian edge, and event context into a concise brief.

✦ Unlock with Pro

Wikipedia Attention

Price History · 30 days

Export CSV

Price History

MarketFM Estimate

+49.3pp

Research Summary

Prediction markets currently price "FDA approves Sanofi's Dupixent?" at 80% YES / 20% NO. In the last 24 hours, $3K has been traded. A Bayesian estimate puts the probability at 81%. The bid-ask spread is 9.00pp. The market closes on April 27, 2026.

Cite this snapshot

ForecastMind (2026-04-23). "FDA approves Sanofi's Dupixent?." Prediction market snapshot: YES 80%, NO 20%. Retrieved from https://forecastmind.org/markets/2036554